Source: Annual Congress 2009 - Pulmonary circulation II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Ahmad, Z. Ammen, K. Srinivasan, H. Moudgil (Telford, United Kingdom). Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies. Eur Respir J 2009; 34: Suppl. 53, 3923

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018 Year: 2018 The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Predicting risk of mortality of chronic pulmonary aspergillosis Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)? Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019